Loading the player...
Emerging Clinical Applications of Psychedelic Medicines
During this presentation followed by Q&A discussion, Dr. Barnett will describe various psychedelic compounds, their known mechanisms of action, and various subjective effects. He will review the past and current literature on the potential therapeutic benefits, as well as the risks, of psychedelic medicines on a variety of clinical conditions. Finally, he will discuss “trends and issues” in the broader psychedelic medicine field with a look at future directions. Discussion may also include psychedelic experiences outside of Western medical and research models, such as personal use, indigenous traditions, and religious use.
Rick Barnett, PsyD, MSCP is a licensed clinical psychologist, licensed alcohol and drug counselor with an MS in Clinical Psychopharmacology. He runs a private group practice focusing on adults, older adults, and state-mandated patients for alcohol use and other drug use disorders. He has served as President of APA Society for Prescribing Psychology (Division 55, 2020), President of the VT Psychological Association (2011-2014) and current Chair of the Legislative Committee working on Prescriptive Authority and psilocybin decriminalization in Vermont. He co-founded the Psychedelic Society of Vermont in 2021 after completing a yearlong training in psychedelic psychotherapy and research through the California Institute for Integral Studies (CIIS), and is the Founder and CEO of CARTER, Inc, a 501c3 nonprofit dedicated to the art and science of achieving lifelong freedom from addictive disorders. Rick loves the outdoors, is in long-term recovery from addiction, and enjoys being curious and connecting with others.
